{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:35:52Z","timestamp":1790840152945,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"B*Cured Foundation Brain Cancer Research Investigator Award"},{"name":"Roger Williams Medical Center Brain Tumor Research Fund"},{"DOI":"10.13039\/100008953","name":"Prometheus Laboratories Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008953","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Novartis Corporation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.canlet.2018.06.035","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T19:09:06Z","timestamp":1530126546000},"page":"131-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Glycogen synthase kinase 3 inhibition lowers PD-1 expression, promotes long-term survival and memory generation in antigen-specific CAR-T cells"],"prefix":"10.1016","volume":"433","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5933-4430","authenticated-orcid":false,"given":"Sadhak","family":"Sengupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarshana","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2018.06.035_bib1","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1056\/NEJMoa1504542","article-title":"Chimeric antigen receptor T cells against CD19 for multiple myeloma","volume":"373","author":"Garfall","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2018.06.035_bib2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2018.06.035_bib3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/icb.2016.128","article-title":"CAR T cell therapy of solid tumors","volume":"95","author":"Yong","year":"2017","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.canlet.2018.06.035_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-med-062315-120245","article-title":"CAR T cell therapy for solid tumors","volume":"68","author":"Newick","year":"2017","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.canlet.2018.06.035_bib5","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1158\/1078-0432.CCR-08-3163","article-title":"Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells","volume":"15","author":"Yvon","year":"2009","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2018.06.035_bib6","doi-asserted-by":"crossref","first-page":"8112","DOI":"10.1158\/1078-0432.CCR-07-4910","article-title":"Second-generation anti-carcinoembryonic antigen designer T cells resist activation-induced cell death, proliferate on tumor contact, secrete cytokines, and exhibit superior antitumor activity in vivo: a preclinical evaluation","volume":"14","author":"Emtage","year":"2008","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2018.06.035_bib7","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1002\/ijc.25960","article-title":"Costimulation by chimeric antigen receptors revisited the T cell antitumor response benefits from combined CD28-OX40 signaling","volume":"129","author":"Hombach","year":"2011","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.canlet.2018.06.035_bib8","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMoa1610497","article-title":"Regression of glioblastoma after chimeric antigen receptor T-cell therapy","volume":"375","author":"Brown","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2018.06.035_bib9","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.4049\/jimmunol.1301523","article-title":"Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity?","volume":"191","author":"van der Stegen","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2018.06.035_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1479-5876-2-17","article-title":"Forecasting the cytokine storm following systemic interleukin (IL)-2 administration","volume":"2","author":"Panelli","year":"2004","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2018.06.035_bib11","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1038\/mto.2016.11","article-title":"Toxicity and management in CAR T-cell therapy","volume":"3","author":"Bonifant","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.canlet.2018.06.035_bib12","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/mt.2016.63","article-title":"GD2-specific CAR T cells undergo potent activation and deletion following antigen encounter but can be protected from activation-induced cell death by PD-1 blockade","volume":"24","author":"Gargett","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2018.06.035_bib13","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1172\/JCI83092","article-title":"Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition","volume":"126","author":"Cherkassky","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2018.06.035_bib14","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.aaf2807","article-title":"Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade","volume":"354","author":"Pauken","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.canlet.2018.06.035_bib15","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/j.1460-2075.1990.tb07419.x","article-title":"Molecular cloning and expression of glycogen synthase kinase-3\/factor A","volume":"9","author":"Woodgett","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2018.06.035_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3590001","article-title":"GSK3 takes centre stage more than 20 years after its discovery","volume":"359","author":"Frame","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2018.06.035_bib17","doi-asserted-by":"crossref","first-page":"11410","DOI":"10.1074\/jbc.271.19.11410","article-title":"T-cell activation leads to rapid stimulation of translation initiation factor eIF2B and inactivation of glycogen synthase kinase-3","volume":"271","author":"Welsh","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2018.06.035_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.192.1.99","article-title":"Negative regulation of T cell proliferation and interleukin 2 production by the serine-threonine kinase GSK-3","volume":"192","author":"Ohteki","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2018.06.035_bib19","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.4049\/jimmunol.178.10.6083","article-title":"Unrestrained glycogen synthase kinase-3 beta activity leads to activated T cell death and can be inhibited by natural adjuvant","volume":"178","author":"Sengupta","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2018.06.035_bib20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm.1982","article-title":"Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells","volume":"15","author":"Gattinoni","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2018.06.035_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.immuni.2010.08.002","article-title":"Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1","volume":"33","author":"Zhou","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2018.06.035_bib22","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1158\/1078-0432.CCR-12-0319","article-title":"Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells","volume":"18","author":"Kong","year":"2012","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2018.06.035_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jviromet.2007.12.008","article-title":"Sorting vector producer cells for high transgene expression increases retroviral titer","volume":"148","author":"Beaudoin","year":"2008","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.canlet.2018.06.035_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1189\/jlb.5HI0716-322RR","article-title":"Frontline Science: functionally impaired geriatric CAR-T cells rescued by increased alpha5beta1 integrin expression","volume":"102","author":"Guha","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.canlet.2018.06.035_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.imbio.2005.06.003","article-title":"Adjuvant-induced survival signaling in clonally expanded T cells is associated with transient increases in pAkt levels and sustained uptake of glucose","volume":"210","author":"Sengupta","year":"2005","journal-title":"Immunobiology"},{"key":"10.1016\/j.canlet.2018.06.035_bib26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.immuni.2016.01.018","article-title":"Glycogen synthase kinase 3 inactivation drives T-bet-mediated downregulation of Co-receptor PD-1 to enhance CD8(+) cytolytic T cell responses","volume":"44","author":"Taylor","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2018.06.035_bib27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4049\/jimmunol.1501264","article-title":"LFA-1\/ICAM-1 ligation in human T cells promotes Th1 polarization through a GSK3beta signaling-dependent notch pathway","volume":"197","author":"Verma","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2018.06.035_bib28","doi-asserted-by":"crossref","first-page":"9777","DOI":"10.1073\/pnas.0914127107","article-title":"Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory","volume":"107","author":"Jeannet","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2018.06.035_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041074","article-title":"Stimulation of Wnt\/ss-catenin pathway in human CD8+ T lymphocytes from blood and lung tumors leads to a shared young\/memory phenotype","volume":"7","author":"Forget","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2018.06.035_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4614-3146-6_5","article-title":"Mechanisms of immune evasion by gliomas","volume":"746","author":"Rolle","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.canlet.2018.06.035_bib31","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.4049\/jimmunol.181.12.8363","article-title":"Antigenic experience dictates functional role of glycogen synthase kinase-3 in human CD4+ T cell responses","volume":"181","author":"Garcia","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2018.06.035_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2004.09.008","article-title":"Measurement of daughter cell accumulation during lymphocyte proliferation in vivo","volume":"295","author":"Thompson","year":"2004","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.canlet.2018.06.035_bib33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fimmu.2015.00563","article-title":"The Timing of T Cell priming and cycling","volume":"6","author":"Obst","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2018.06.035_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11864-017-0492-y","article-title":"Clinical trials investigating immune checkpoint blockade in glioblastoma","volume":"18","author":"Maxwell","year":"2017","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.canlet.2018.06.035_bib35","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s13311-017-0513-3","article-title":"The role of immune checkpoint inhibition in the treatment of Brain tumors","volume":"14","author":"Luksik","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.canlet.2018.06.035_bib36","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1073\/pnas.0308054101","article-title":"Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets","volume":"101","author":"Huster","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2018.06.035_bib37","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/eji.200635874","article-title":"Unidirectional development of CD8+ central memory T cells into protective Listeria-specific effector memory T cells","volume":"36","author":"Huster","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canlet.2018.06.035_bib38","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1009","article-title":"Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells","volume":"4","author":"Kaech","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2018.06.035_bib39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.coi.2007.04.015","article-title":"Cytokines and T-cell homeostasis","volume":"19","author":"Boyman","year":"2007","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.canlet.2018.06.035_bib40","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A human memory T cell subset with stem cell-like properties","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2018.06.035_bib41","doi-asserted-by":"crossref","first-page":"E7788","DOI":"10.1073\/pnas.1610544113","article-title":"Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells","volume":"113","author":"Hurton","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518304415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518304415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T22:28:41Z","timestamp":1571524121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383518304415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":41,"alternative-id":["S0304383518304415"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2018.06.035","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycogen synthase kinase 3 inhibition lowers PD-1 expression, promotes long-term survival and memory generation in antigen-specific CAR-T cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2018.06.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}